-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Orchestra BioMed Holdings, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2022 to Q3 2024.
- Orchestra BioMed Holdings, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $17.3M, a 16% increase year-over-year.
- Orchestra BioMed Holdings, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $62.8M, a 19.6% increase year-over-year.
- Orchestra BioMed Holdings, Inc. annual Costs and Expenses for 2023 was $54.3M, a 49.9% increase from 2022.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)